Potential improvement in weight-related health conditions
Professional guidelines from major organisations, including the American Society of Anesthesiologists, the American Gastroenterological Association, the Australian and New Zealand College of Anaesthetists, the Association of Anaesthetists (UK), and regulatory guidance from health authorities, were specifically reviewed
Shah P, Ardestani A, Dharmadhikari G, Laue S, Schumann DM, Kerr-Conte J, et al
Wegovy injection showed weight loss of 15% in its key trial, versus 2% for placebo, while Zepbound showed 21% on its highest dose, compared with 3% for those on placebo
GLP-1 medications like Ozempic and Wegovy help protect heart health, but stopping the medications may reduce the protective effects
These factors include the ingredients' quality, the type of medical facility providing the treatment, geographic location, and prescribed treatment protocols